18F-FDGPET与99Tcm-MDP骨显像在诊断肿瘤骨转移中的比较

陶欣慰 ,  黄钢

downloadPDF
文章导航 > 国际放射医学核医学杂志  > 2010,  34 > 6: (352-355)  
引用本文:
shu
Citation:
shu

18F-FDGPET与99Tcm-MDP骨显像在诊断肿瘤骨转移中的比较

  • 上海市仁济医院核医学科, 200127

Comparasion of 18F-FDG PET and 99Tcm-MDP bone imaging in diagnosis of bone metastasis

  • Department of Nuclear Medicine, Renji Hospital, Shanghai Jiaotong University, Shanghai 200127, China

  • 摘要: 恶性肿瘤发生骨转移将大大影响患者的生存率、降低患者的生活质量。PET和骨显像作为两种常见的评估全身骨骼情况的显像模式,能早期发现骨转移,进行肿瘤分期,帮助临床治疗。通过两种显像的原理,可以分析不同骨质破坏的病理类型的诊断差异和侧重点。除PET和骨显像之外,MRI也是灵敏度很高的影像学检查方法之一。此外,新型PET示踪剂的出现和PET-CT、SPECT-CT融合显像必将为核医学探测肿瘤骨转移提供新的价值。
    Abstract: Bone metastasis from malignant tumor will reduce the survival rate and life quality of patients. As the most two common procedures of evaluating the condition of whole-body skeletal system, both 18F-FDG PET and 99Tcm-MDP bone imaging can detect early metastasis and stage the cancer, thus helping the treatment. With the help of the theory of these two imaging methods, diagnostic differences and points of focus in different pathological types of bone destruction can be analyzed. Except PET and bone imaging, MRI is also an imaging method with high sensitivity. Moreover, PET-CT, SPECT-CT and some newly-discovered tracers will certainly add new value on detecting bone metastasis by methods of nuclear medecine.
  • [1] Ozülker T,Kücüköz Uzun A,Oztllker F,et al.Comparison of 88F-FDG-PET/CT with 99mTc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.Nucl Med Commun,2010,31(6):597-603.
    [2] Messiou C,Cook G,deSouza NM.Imaging metastatic bone disease from carcinoma of the prostate.Br J Cancer.2009,101(8):1225-1232.
    [3] Bury T,Barreto A,Daenen F,et ah Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.Eur J Nucl Med,1998,25(9):1244-1247.
    [4] Cheran SK,Herndon JE 2nd,Patz EF Jr.Comparison of wholebody FDG-PET to bone scan for detection of bone melastases in patients with a new diagnosis of lung cancer.Lung Cancer,2004,44(3):317-325.
    [5] Stefan K,Andreas K,Buck Felix M,et al.Detection of bone metastases in patients with lung cancer 99mTc-MDP planar bone scintigraphy,88F-fluoride PET or 88F-FDG PET/CT.Eur J Nucl Med Mol Imaging,2009,36(11):1807-1812.
    [6] Marom EM,McAdams HP,Erasnms J,et al.Staging non-small cell lung cancer with whole-body PET.Radiology,1999,212(3):803-809.
    [7] Buck AK,Herrmann K,Stargardt T,et al.Economic evaluation of PET and PET/CT in Oncology:evidence and methodologic approaches.J Nucl Med Technol,2010,38(1):6-17.
    [8] Cook GJ.Skeletal metastases:what is the future role for nuclear medicine?.Eur J Nucl Med Mol hnaging,2009,36(11):1807-1812.
    [9] Ito S,Kato K,Ikeda M,et al.Comparison of 88F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid eaneer.J Nucl Med,2007,48(6):889-895.
    [10] Hamaoka T,Madewell JE,Podoloff DA,et al.Bone imagingingmetastatic breast cancer.J Clin Oncol,2004,22(14):2942-2953.
    [11] Goya M,Ishii G,Miyamoto S,et al.Prostate-specific antigen induces apoptosis of osteoclast precursors:potential role in osteoblastie bone metastases of prostate cancer.Prostate,2006,66(15):1573-1584.
    [12] Mundy GR.Metastasis to bone:causes,consequences and thera-peutic opportunities.Nat Rev Cancer,2002,2(8):584-593.
    [13] Uematsu T,Yuen S,Yukisawa S.et al.Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer.AJR Am J Roentgenol,2005,184(4):1266-1273.
    [14] Ohla M,Tokuda Y,Suzuki Y evaluation of bony metastases et al.Whole body PET for the in patients with breast cancer:comparisnn with 99mTc-MDP bone scintigraphy.Nucl Med Comnmn 2001,22(8):875-879.
    [15] Schin'meister H,Guhlmann A,Eisner K,et al.Sensitivity in detecting osseous lesions depends on anatomic localization:planar bone scintigraphy versus tSF PET.J Nucl Med,1999,40(10):1623-1629.
    [16] Metser U,Lerman H,Blank A,et al.Malignant involvement of the spine:assessment by 88F-FDG PET/CT.J Nucl Med,2004,45(2):279-284.
    [17] Nakai T,Okuyama C,Kubota T,et al.Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer.EurJ Nucl Med Mol Imaging,2005,32(11):1253-1258.
  • [1] 陶欣慰 , 黄钢 . F-FDGPET与 99Tcm-MDP骨显像在诊断肿瘤骨转移中的比较. 国际放射医学核医学杂志, 2010, 34(6): 352-355. doi: 10.3760/cma.j.issn.1673-4114.2010.06.008
    [2] 徐海青 , 段俊 , 吴边 . 全身骨显像诊断前列腺癌骨转移与PSA水平及病理分级的相关性研究. 国际放射医学核医学杂志, 2011, 35(1): 34-37. doi: 10.3760/cma.j.issn.1673-4114.2011.01.010
    [3] 刘道佳 , 唐明灯 , 林端瑜 , 倪雷春 , 林小敏 . 99Tcm-MDP全身骨显像、99Tcm-MDP SPECT-CT和18F-FDG SPECT-CT探测脊柱转移瘤的比较. 国际放射医学核医学杂志, 2011, 35(2): 89-92. doi: 10.3760/cma.j.issn.1673-4114.2011.02.006
    [4] 张胤 , 陈跃 . 18F-氟化钠PET/CT诊断肿瘤骨转移应用进展. 国际放射医学核医学杂志, 2015, 39(1): 96-102. doi: 10.3760/cma.j.issn.1673-4114.2015.01.020
    [5] 袁超 , 陶健 , 袁媛 , 孙伟莉 . 血清CA15-3、CEA及全身骨显像联合检查对乳腺癌骨转移的诊断价值. 国际放射医学核医学杂志, 2009, 33(6): 353-355. doi: 10.3760/cma.j.issn.1673-4114.2009.06.011
    [6] 秦丽军 , 李万婷 , 武志芳 , 陆克义 , 刘建中 , 胡光 , 李思进 , 刘海燕 . 99Tcm-MDP SPECT/CT骨显像在绝经后女性骨质疏松性胸腰椎椎体骨折中的增益价值. 国际放射医学核医学杂志, 2017, 41(3): 173-177. doi: 10.3760/cma.j.issn.1673-4114.2017.03.003
    [7] 于亚萍 , 李永亮 , 冯蓓 , 姜杨宏岩 , 赵倩 . SPECT/CT超级骨显像影像学特征、临床表现、年龄及实验室检查指标的分析. 国际放射医学核医学杂志, 2022, 46(6): 325-333. doi: 10.3760/cma.j.cn121381-202107030-00192
    [8] 吴凡 , 李林法 , 易贺庆 . α粒子放射性药物在骨转移瘤治疗中的应用进展. 国际放射医学核医学杂志, 2022, 46(2): 112-115. doi: 10.3760/cma.j.cn121381-202106027-00134
    [9] 叶慧 , 莫逸 , 谢爱民 , 彭翔 . 18F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究. 国际放射医学核医学杂志, 2008, 32(3): 147-150.
    [10] 冯菲 , 赵德善 , 耿会霞 , 吴利翔 , 刘建中 , 李思进 . 原发性腹膜砂粒体癌99Tcm-亚甲基二膦酸盐SPECT-CT全身骨显像一例报告. 国际放射医学核医学杂志, 2009, 33(5): 285-286. doi: 10.3760/cnla.j.issn.1673-4114.2009.05.009
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  1534
  • HTML全文浏览量:  1033
  • PDF下载量:  5
出版历程
  • 收稿日期:  2010-05-25

18F-FDGPET与99Tcm-MDP骨显像在诊断肿瘤骨转移中的比较

  • 上海市仁济医院核医学科, 200127
  • 收稿日期: 2010-05-25

摘要: 恶性肿瘤发生骨转移将大大影响患者的生存率、降低患者的生活质量。PET和骨显像作为两种常见的评估全身骨骼情况的显像模式,能早期发现骨转移,进行肿瘤分期,帮助临床治疗。通过两种显像的原理,可以分析不同骨质破坏的病理类型的诊断差异和侧重点。除PET和骨显像之外,MRI也是灵敏度很高的影像学检查方法之一。此外,新型PET示踪剂的出现和PET-CT、SPECT-CT融合显像必将为核医学探测肿瘤骨转移提供新的价值。

English Abstract

    全文HTML

参考文献 (17)

目录

    /

    返回文章
    返回

    版权所有©中华医学会   备案号：津ICP备15006720号-3

    地址：天津市南开区白堤路238号电话：86-22-58089989
    86-22-85682389    传真：022-87890607

    本系统由 北京仁和汇智信息技术有限公司 开发 技术支持： info@rhhz.net